BAP Officer Details

Secretary for Non-Clinical External Affairs

Dr Sarah Bailey

Sarah Bailey

University of Bath
Secretary for Non-Clinical External Affairs until 2021

I am currently a Senior Lecturer in the Department of Pharmacy and Pharmacology, University of Bath. My research focuses on understanding the molecular mechanisms underlying the response to stress, the development of depression related behaviours and how we can use this knowledge to inform antidepressant development. Following a Wellcome Trust Advanced Training Fellowship in 1999-2002 at Weill Cornell Medical College, New York, I returned to the University of Bristol as a lecturer in the School of Medical Sciences before moving to Bath in 2005. I teach pharmacology and neuroscience to pharmacy and pharmacology students. I run an in vivo skills module, enabling pharmacology undergraduate students to complete Home Office licence training and get hands-on experience in behavioural psychopharmacology. I am Chair of our Animal Users Committee and support the work of Understanding Animal Research to promote openness on animal research.

I have been an enthusiastic member of BAP for 15 years and have attended and contributed to almost every annual meeting since joining. I was elected to BAP Council by the membership in 2013. On Council I have worked to support the non-clinical membership of BAP through developing specific non-clinical workshops at the annual summer meeting and by fostering partnerships with the British Pharmacological Society and British Neuroscience Association through e.g. joint symposia. The BAP is an important forum for psychopharmacology. As Secretary for Non-Clinical External Affairs I will continue work to strengthen the networking opportunities for all non-clinical scientists within the association, with the aim of developing and sharing experimental expertise. Building on my experience in the British Pharmacological Society’s Animal Welfare and In-Vivo Pharmacology Group, I will also work to support the role of the BAP in meeting its commitments under the Concordat on Openness on Animal Research across the range of BAP’s activities. Through representation at external bodies and policy work I hope to support the recognition and importance of non-clinical scientists, with a wide-range of skills and expertise in experimental neuroscience, in essential psychopharmacology research in the UK.

Declaration of Interests

  1. Have you, in the past three years, had patents or inventions from which you may derive personal benefit in the area of psychopharmacology?
  2. No
  3. Have you, in the past three years, had ownership or part ownership of a company with interests in the area of psychopharmacology? (This would include holding the shares of major companies in one's own name, or those of dependent family members.)
  4. No
  5. Have you, in the past three years, accepted a personal retainer from any company with an interest in psychopharmacology?
  6. No
  7. Have you, in the past three years, acted as a consultant to any company with an interest in psychopharmacology?
  8. No
  9. Have you, in the past three years, acted as an expert witness, either friendly or hostile, to any company with an interest in psychopharmacology?
  10. No
  11. Have you, in the past three years, held a research grant from any company with an interest in psychopharmacology?
  12. MRC Industrial CASE Studentship with Janssen Pharmaceutics 2012-2016
  13. Have you, in the past three years, had membership of the speakers' bureau for any company?
  14. No
  15. Have you, in the past three years, accepted paid speaking engagements in industry supported symposia?
  16. No
  17. Have you, in the past three years, accepted travel or hospitality NOT related to a speaking engagement?
  18. No
  19. Have you, in the past three years, recruited patients for industry-sponsored studies?
  20. No
  21. If there is anything else you feel it necessary to disclose, please provide details below:

Form completed on 6th September 2018